JTL
PTCT icon

Jupiter Topco LLC’s PTC Therapeutics PTCT Stock Holding History

Jupiter Topco LLC’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$590M Buy
+7,236,402
New +$523M 0.24% 92

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Jupiter Topco LLC's PTCT Position: Q2 2026 in Review

Jupiter Topco LLC opened a new position in PTC Therapeutics (PTCT) in Q2 2026: 7,236,402 shares worth $590M. The stake represents 0.24% of the portfolio and ranks #92 among its holdings.

355 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Jupiter Topco LLC held 7,236,402 shares of PTC Therapeutics worth $590M as of Q2 2026.
  • PTC Therapeutics was a new Jupiter Topco LLC position in Q2 2026.
  • PTC Therapeutics made up 0.24% of Jupiter Topco LLC's portfolio in Q2 2026, its #92 holding.
  • 355 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Jupiter Topco LLC's 13F filing for Q2 2026, filed 14 Aug 2026.